NCT04955015

Brief Summary

Stroke is one of the leading causes of death and disability-adjusted life-years worldwide. Carotid high-risk atherosclerotic plaques are considered to be one of the major sources of ischemic stroke. The present study aimed to investigate the relationship of carotid plaque characteristics with brain perfusion and cognitive function in patients undergoing carotid endarterectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 8, 2021

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

July 8, 2021

Status Verified

June 1, 2021

Enrollment Period

1.9 years

First QC Date

June 29, 2021

Last Update Submit

June 29, 2021

Conditions

Keywords

atherosclerosiscarotid endarterectomyperfusioncognition

Outcome Measures

Primary Outcomes (2)

  • brain perfusion

    perioperative brain perfusion and changes of brain perfusion in patients underging CEA

    From preoperative to 24 months after operation (CEA)

  • cognitive function

    perioperative cognitive function and cognitive changes in patients underging CEA

    From preoperative to 24 months after operation (CEA)

Study Arms (1)

patients

patients with caotid atherosclerosis refering to carotid endarterectomy

Procedure: carotid endarterectomy

Interventions

patients with carotid atherosclerosis refering to CEA

patients

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with carotid atherosclerosis refering to CEA in our hospital

You may qualify if:

  • Over 30 years old;
  • The patients with symptomatic (\>50%) or asymptomatic carotid stenosis (\> 70%) measured by computed tomography angiography (CTA) or B-mode ultrasonography
  • CEA operation will be performed in our hospital.

You may not qualify if:

  • The history of CEA operation in the last 3 months;
  • Diseases (AF, valve diseases, etc.) that may cause cardiac thrombosis;
  • Contraindications of MR examination (vascular stent implantation, pacemaker, metal or magnetic plants in vivo, claustrophobia, etc.) were found;
  • Contraindications of contrast agents: such as renal failure, iodine or gadolinium contrast agent allergy;
  • Having heart or respiratory failure;
  • Serious consciousness disorder (coma, etc.);
  • Brain tumor;
  • Acute cerebral hemorrhage;
  • Pregnant women or planned pregnancies in the past 2 years;
  • Who does not agree to sign the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, China

RECRUITING

MeSH Terms

Conditions

Atherosclerosis

Interventions

Endarterectomy, Carotid

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

EndarterectomyVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Huishu Yuan, Dr.

    Peking University Third Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2021

First Posted

July 8, 2021

Study Start

September 1, 2019

Primary Completion

July 31, 2021

Study Completion

July 31, 2023

Last Updated

July 8, 2021

Record last verified: 2021-06

Locations